Autism in Aotearoa: Is the RAADS14 a valid tool for a New Zealand population. Correction to Kember & Williams, 2021.

Reports an error in "Autism in Aotearoa: Is the RAADS-14 a valid tool for a New Zealand population" by Sarah M. Kember and Matt N. Williams (European Journal of Psychological Assessment, 2021, Vol 37[3], 247-257). In the article (https://doi.org/ 10.1027/1015-5759/a000598) some minor numeric errors have been detected and corrections are listed in the erratum. However, none of these errors impacts the findings on the hypotheses, nor the conclusions drawn. These errors relate primarily to the reported sample size and related figures (degrees of freedom and subsample sizes). This was due to the use of an earlier version of the R script when drafting parts of the article. (The following abstract of the original article appeared in record 2020-50277-001.) Screening measures for autism spectrum disorder (ASD) are important tools for clinicians and researchers. However, where a measure developed and validated for one population is used with another, its performance in this new context must be carefully examined. The RAADS-14, a brief ASD screen developed in Sweden, was evaluated with a sample of New Zealand adults (N = 387), 41 of whom self-reported a prior diagnosis of ASD. The convergent validity of the RAADS-14 (Hypothesis 2) was supported by a strong positive correlation with the AQ-10 (short version of the Autism Spectrum Quotient), r = .81. Discriminant validity (Hypothesis 3) was also supported by a strong negative correlation with the EQ-Short (short version of the Empathy Q...
Source: European Journal of Psychological Assessment - Category: Psychiatry & Psychology Source Type: research